, Topley & Wilson's microbiology & microbial infections, vol.2, pp.1035-88, 2005.
, La classe des Clostridia. In: Microbiologie. Bruxelles
Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as « Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus, Zeitschrift für Hygiene und Infektionskrankheiten, vol.73, issue.2, pp.701-720, 1897. ,
Botulism: the organism, its toxins, the disease ,
USA: Thomas, 1988. ,
The taxonomic position of Clostridium botulinum type ,
, Onderstepoort J Vet Res. juin, vol.44, issue.2, pp.53-57, 1977.
,
, Soc Exp Biol Med, vol.35, issue.2, pp.278-80, 1936.
Preliminary report on the isolation of an apparently new type of CI. botulinum, Acta Pathol Microbiol Scand, vol.48, p.99, 1960. ,
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins, Collège des universitaires de maladies infectieuses et tropicales (France). Botulisme. In: Maladies infectieuses et tropicales. la santé publique -Article, vol.209, pp.183-91, 2014. ,
, Code de la santé publique -Article D3113-6. Code de la santé publique
, Caractéristiques épidémiologiques du botulisme humain en 2016
,
, , pp.46-55, 2003.
,
, Ann Dermatol Venereol. mai, vol.136, pp.73-76, 2009.
Toxines botuliques : mode d action ,
How botulinum and tetanus neurotoxins block neurotransmitter release, Biochimie. mai, vol.82, issue.5, pp.427-473, 2000. ,
Botulinum toxin as a biological weapon: medical and public health management, JAMA. 28 févr, vol.285, issue.8, 2001. ,
Botulinum Toxin as a Biological Weapon ,
, JAMA. 28 févr, vol.285, issue.8, pp.1059-70, 2001.
La toxine botulique en médecine physique et réadaptation, 2006. ,
Manual of botulinum toxin therapy ,
Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery, Ophthalmology. oct, vol.87, issue.10, pp.1044-1053, 1980. ,
Bonventre PF, Kempe LL. Physiology of toxin production by Clostridium botulinum types A and B. IV. Activation of the toxin, 26. Frevert J. Xeomin is free from complexing proteins. Toxicon Off J Int Soc Toxinology, vol.12, issue.4, pp.697-701, 1960. ,
Conversion Ratio between Botox®, Dysport®, and Xeomin® in ,
,
,
Réflexion sur la manière de sécuriser le circuit de la toxine botulique au CHU de Grenoble ,
,
,
Plan de gestion de risque des spécialités pharmaceutiques à base de toxine botulinique A ou B ,
,
, PHP: Hypertext Preprocessor, Usage Statistics and Market Share of Server-side Programming Languages
, , 2018.
, , p.28
,
,